Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging the HIV Reservoir with 3BNC117-Copper-64
NCT03063788Phase 1Completed
- Start
- Sep 2018
- Primary completion
- Feb 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, open-label trial of 3BNC117 + copper-64 in human immunodeficiency virus infection (HIV) (3 arms). Primary endpoint: Standard Uptake Value at 2 days. Started Sep 2018; status: completed.
02
Drugs
3BNC117 + copper-64
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03063788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03063788.